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Three adaptive hypotheses have been proposed to explain the link between the human leucocyte antigen (HLA) genes, health
measures and facial attractiveness: inbreeding avoidance, heterozygote advantage and frequency-dependent selection. This
paper reports findings that support a new hypothesis relating HLA to health. We suggest a new method to quantify the level of
heterozygosity. HLA heterozygosity did not significantly predict health measures in women, but allele frequency did. Women
with more common HLA alleles reported fewer cold and flu bouts per year, fewer illnesses in the previous year and rated
themselves healthier than women with rare alleles. To our knowledge, this is the first study to show a positive correlation
between HLA allele frequency and general health measures. We propose that certain common HLA alleles confer resistance to
prevalent pathogens. Nevertheless, neither HLA heterozygosity nor allele frequency significantly predicted how healthy or
attractive men rated the female volunteers. Three non-mutually exclusive explanations are put forward to explain this finding.
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INTRODUCTION
Evolutionary theory predicts that individuals should choose
partners that will increase the number and quality of offspring
produced, and that such choices will be based on phenotypic
characteristics associated with the ability to supply partners and
offspring with direct and indirect benefits. Direct benefits include
the ability of the potential partner to provide resources, such as
food, shelter, parental care and protection from parasite due to his
own reduced parasite load [1]. These benefits have an immediate
effect on reproductive success [1]. An individual also benefit
indirectly from choosing a partner with traits that indicate their
‘‘high quality’’. Hamilton and Zuk [2] proposed that these ‘‘high
quality’’ traits or ‘‘good genes’’ could relate to disease resistance in
the potential partner. Disease resistance can be judged by a wide
array of traits including bright plumage, symmetry or even
a vigorous courtship display. If a male cannot cope with the
continuous onslaught of pathogens his sexual signals would
deteriorate and the display would be somewhat less thrilling.
These genes will be passed on to the offspring reducing their
inherent resistance to disease.
Conventionally females are considered the choosier sex, because
of their excessive reproductive investment in offspring [3].
However, humans have a resource-based mating system and
men invest substantially in offspring, especially since offspring only
become independent relatively late in life. Women, therefore,
prefer men that can shoulder such a large resource-based burden,
and these men in turn are choosier about the women they select as
partners [3–5]. Thus, in humans at least, both sexes prefer
partners that can provide them with direct and indirect benefits.
Though males traditionally provide most of the direct benefits in
the form of food, shelter and protection against predators and
parasites [6], both sexes benefit indirectly from choosing ‘‘high
genetic quality’’ partners, as these ‘‘good genes’’ are inherited by
offspring, and confer survival and/or reproductive advantages.
But what exactly is ‘‘genetic quality’’? According to Neff&-
Pitcher [7] ‘‘genetic quality’’ can be defined as the sum of two
components: additive genetic effects or ‘‘good genes’’ and non-
additive genetic effects or ‘‘compatible genes’’. Specific alleles that
increase fitness independently of the rest of the genome contribute
to additive genetic benefits, while heterozygote advantage and
epitasis contribute to non-additive genetic benefits. Both additive
and non-additive genetic effects are considered important
determinants of ‘‘genetic quality’’ and by implication, of mate
choice (for a review see [7]).
One of the best-studied genetic based mating systems in
vertebrates is the major histocompatibility complex (MHC). The
MHC plays an essential role in immune response, where it serves
as antigen presenting molecules [8,9]. Several previous studies
have linked the MHC to mating preferences in mice [10–12],
savannah sparrows [13], Atlantic salmon [14] and humans [15],
although there are also studies that show no such effects (Soay
sheep [16]; humans [17–19]).
According to past research MHC based mating preferences are
primarily driven by inbreeding avoidance, heterozygote advantage
and frequency dependent selection (for a review see [20]). Since
specific rare alleles confer fitness benefits under frequency-
dependent selection, and such alleles would still confer these
benefits without the contribution of any other alleles, frequency-
dependent selection is driven by additive genetic effects.
In a recent study, Roberts et al. [21] linked a form of ‘‘genetic
quality’’, HLA heterozygosity, to a sexually selected trait, facial
attractiveness. They showed that HLA heterozygous men are
perceived healthier and more attractive than more HLA
homozygous men. A previous study by Thornhill et al. [22] did
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attractiveness among males. Moreover, a more recent study [23]
did not find a significant relationship between facial attractiveness
and health-history measures. The preference for HLA heterozy-
gosity observed by Roberts et al. [21] could be due to two, non-
mutually exclusive, HLA based mating preferences. First,
individuals might prefer heterozygous mates because such
individuals will confer direct benefits in the form of increased
health and therefore better resource-holding potential, or indirect
benefits in the form of more heterozygous offspring [24]. Secondly,
the preference for heterozygosity could be a by-product of
a preference for ‘‘rare alleles’’, because heterozygous individuals
are more likely to possess such rare alleles than homozygous
individuals [22]. Our objectives were to (a) investigate the health
benefits associated with the two pathogen-driven selection
pressures: frequency dependent selection and heterozygote
advantage and (b) the role of heterozygote advantage and
frequency dependent selection, in predicting HLA based facial
preferences. We achieved both objectives. Our study differs from
previous studies in three important respects. First, we tested male
choice of female partners, rather than female preferences for
males. This is because human males also contribute substantially
to offspring, and males should therefore be equally choosy about
the quality of their mates. To date, male preferences of this kind
have been largely ignored in the literature. Second, our sample
population group has a much higher pathogen load than
previously studied populations [25]. Therefore, one might expect
stronger selection by pathogen-driven selective forces (heterozy-
gote advantage, frequency dependent selection and fluctuating
selection [26]) in our population than in populations with a lower
pathogen load. Third, we also looked at genetic distance between
alleles, rather than just heterozygosity per se. Since the amount of
overlap between HLA molecules (and therefore the genetic
distance between these molecules) dictate the extent of the benefit
associated with heterozygosity [27], genetic distance will serve as
a more sensitive measure of heterozygosity.
RESULTS
Allele (Table 1) and phenotype frequencies were submitted to
http://www.allelefrequencies.net and are available in the category
South African Tswana
(a) HLA heterozygosity, health and facial
attractiveness
We found no significant difference in any of the health or
attractiveness measures between the heterozygous and homozy-
gous groups. Heterozygous females did not rate themselves as
significantly healthier than homozygotes (t39=20.323, p=0.748),
nor did they report fewer illnesses in the previous year (t38=0.028,
p=0.977) or cold and flu bouts per year (t37=0.087, p=0.931;
Discrepancies in degrees of freedom are due to omitted answers on
illnesses in the previous year [1 participant] and number of cold
and flu bouts per year [2 participants]). Male raters also did not
rate heterozygous females as being significantly healthier
(t39=20.130, p=0.897) or more attractive (t39=1.186,
p=0.243).
We calculated combined genetic distances for both HLA loci as
a second measure of HLA heterozygosity (Figure 1). These were
used to test associations between HLA genetic distance (as
a continuous measure of HLA heterozygosity) and health and
attractiveness measures. Genetic distance did not significantly
predict self-rated health (F1,37=1.229, R
2=0.032, p=0.275),
number of illnesses in the previous year (F1,35=0.356, R
2=0.010;
p=0.555) or number of cold and flu bouts per year (F1,34=0.242,
R
2=0.007; p=0.626). In addition, larger genetic distances did not
predict how healthy (F1,38=0.532, R
2=0.014, p=0.470) or
attractive (F1,37=0.017, R
2,0.001; p=0.897) females were rated
by the opposite sex.
(b) HLA allele frequency, health and facial
attractiveness
Combined allele frequency (averaged for HLA-A and HLA-B)
significantly predicted the number of cold and flu bouts per year
(equation: Cold and flu bouts=5.536–18.7436allele frequency,
F1,34=5.618, R
2=0.142, p=0.024; Figure 2), and predicted self-
rated health and number of illnesses in the previous year after the
removal of influential outliers (Self-rated health: equation: Self-
rated health=74.715+288.086allele frequency, F1,37=6.587,
R
2=0.151, p=0.014; Figure 3)(Number of illnesses: equation:
Ill previous year=4.089–16.2456allele frequency, F1,35=5.014,
R
2=0.125, p=0.032; Figure 4), and not before (Self-rated health:
F1,39=2.221, R
2=0.054, p=0.144)(Number of illnesses:
F1,38=2.357, R
2=0.058, p=0.133; Table 2). However, the effect
of illnesses per year was robust enough to give a marginally
significant (p=0.06) rank correlation before the removal of
outliers. Interestingly, these results show that females with high
combined allele frequencies (i.e., those with more common alleles)
considered themselves healthier and reported fewer illnesses.
Conversely, combined allele frequencies did not significantly
predict how healthy or attractive females were rated by the
opposite sex (Health: F1,36=0.175, R
2=0.005, p=0.678; attrac-
tiveness: F1,34=2.421, R
2=0.066, p=0. 129; Table 2).
Next, we tested if the effect of the combined allele frequency can
be explained by either HLA-A or HLA-B. HLA-B allele frequency
did not significantly predict self-rated health (F1,35=1.185,
R
2=0.033, p=0.284), while HLA-A allele frequency significantly
Table 1. HLA-A and HLA-B allele frequencies of the South
African Tswana population.
......................................................................
Allele Allele frequency Allele Allele frequency
HLA-A HLA-B
A*30 0.159 B*58 0.220
A*02 0.146 B*15 0.159
A*29 0.122 B*44 0.116
¤
A*68 0.122 B*45 0.110
¤¤
A*03 0.085 B*42 0.085
A*23 0.085 B*13 0.061
A*34 0.073 B*14 0.061
A*43 0.049 B*18 0.049
A*66 0.037 B*08 0.037
A*26 0.024 B*81 0.037
A*01 0.012 B*07 0.024
A*31 0.012 B*50 0.018
¤
A*32 0.012 B*40 0.012
A*36 0.012 B*35 0.006
¤
A*80 0.012 B*53 0.006
¤
Alleles are arranged from most common to least common in each locus.
¤=Three individuals showed ambiguous allele classifications for HLA-B (44&45/
44&50; 7&35/7&53; 13&44/13&45). In such cases both ambiguous alleles were
awarded a half score).
doi:10.1371/journal.pone.0000640.t001
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PLoS ONE | www.plosone.org 2 July 2007 | Issue 7 | e640predicted self-rated health after the removal of outliers (equation:
Self-rated health=71.347+329.5346allele frequency, F1,37=8.946,
R
2=0.195, p=0.005; Figure 5) but not before (F1,39=3.390,
R
2=0.080, p=0.073). On the other hand, HLA-B allele frequency
significantly predicted the number of cold and flu bouts per year
(equation: Cold&Flu bouts=5.079–13.6866allele frequency,
F1,34=5.829, R
2=0.146, p=0.021; Figure 6), while HLA-A allele
frequencydidnot(F1,36=0.038,R
2=0.001,p=0.847).NeitherHLA-
Figure 1. Frequency of genetic distances averaged over HLA-A and HLA-B. Homozygotes are indicated in green and heterozygotes in red.
doi:10.1371/journal.pone.0000640.g001
Figure 2. The relationship between combined allele frequency and the number of self reported cold and flu bouts per year. Outliers are
indicated as open circles.
doi:10.1371/journal.pone.0000640.g002
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PLoS ONE | www.plosone.org 3 July 2007 | Issue 7 | e640A allele frequency nor HLA-B allele frequency significantly
predicted the number of illnesses in the previous year (HLA-A,
F1,35=3.182,R
2=0.083,p=0.083)(HLA-B,F1,35=2.937,R
2=0.077,
p=0.095).
On their own, neither HLA-A allele frequency nor HLA-B
allele frequency significantly predicted health or attractiveness
ratings by males (Health: HLA-A: F1,35=1.412, R
2=0.039,
p=0.243; HLA-B: F1,36=0.458, R
2=0.013, p=0.503; attrac-
Figure 3. The relationship between combined allele frequency and self-rated health. Outliers are indicated as open circles.
doi:10.1371/journal.pone.0000640.g003
Figure 4. The relationship between combined allele frequency and the number of self reported illnesses in the previous year. Outliers are
indicated as open circles.
doi:10.1371/journal.pone.0000640.g004
Common HLA Alleles and Health
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2=0.020, p=0.392; HLA-B:
F1,36=0.114, R
2=0.003, p=0.738).
DISCUSSION
Our results show that women with more common HLA class I
alleles rated themselves healthier and reported fewer illnesses,
although the class I loci responsible for the beneficial effects
differed between health measures. To our knowledge, this is the
first study to directly report a positive correlation between HLA
allele frequency and general health measures. However, HLA
heterozygous women do not report that they are healthier than
more homozygous women, nor do they report fewer illnesses. This
was true for both the categorical measure of heterozygosity and
genetic distance as a measure of heterozygosity. This lack of
significance could potentially be due to a small sample size and the
consequent lack of statistical power.
One plausible explanation for this novel finding is that, contrary
to what might normally be expected, certain common alleles
increase an individual’s ability to resist specific pathogens. Several
previous studies have shown a correlation between specific HLA
class I alleles and resistance to chronic Hepatitis B [28], malaria
[29] and delayed progression to AIDS [30]. In all three studies,
resistance was conferred by alleles that were common in the
respective study populations. These findings cannot explain the
high allele diversity at HLA loci, which may be driven by less
frequent diseases or by inbreeding avoidance. Although we found
no evidence for heterozygote advantage, this does not mean that
heterozygote advantage cannot drive pathogen-related selection.
Our results show only that the benefit associated with the different
adaptive hypotheses is likely to be context-specific. HLA
heterozygote advantage is expected to be less beneficial in
a situation where a few common pathogens cause most ailments.
In African populations, most of the infectious diseases are caused
by a few common pathogens [31]. In such a scenario, one might
Table 2. HLA allele frequency as a predictor of health and
attractiveness measures.
......................................................................
Source Df F p R
2
Self-rated health
Both loci 1, 37 6.587 0.014 0.151
HLA-A 1, 37 8.946 0.005 0.195
HLA-B 1, 35 1.185 0.284 0.033
Number of times Ill last year
Both loci 1, 35 5.014 0.032 0.125
HLA-A 1, 35 3.182 0.083 0.083
HLA-B 1, 35 2.937 0.095 0.077
Cold&Flu’s per year
Both loci 1, 34 5.618 0.024 0.142
HLA-A 1, 36 0.038 0.847 0.001
HLA-B 1, 34 5.829 0.021 0.146
Rated health
Both loci 1, 36 0.175 0.678 0.005
HLA-A 1, 35 1.412 0.243 0.039
HLA-B 1, 36 0.458 0.503 0.013
Rated attractiveness
Both loci 1, 34 2.421 0.129 0.066
HLA-A 1, 37 0.751 0.392 0.020
HLA-B 1, 36 0.114 0.738 0.003
Significant predictors are indicated in bold.
doi:10.1371/journal.pone.0000640.t002
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Figure 5. The relationship between HLA-A allele frequency and self–rated health. Outliers are indicated as open circles.
doi:10.1371/journal.pone.0000640.g005
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PLoS ONE | www.plosone.org 5 July 2007 | Issue 7 | e640expect an exceptional health benefit from alleles that confer
resistance to these major pathogens. HLA heterozygosity un-
doubtedly contributes to general resistance to pathogens, but the
specific alleles that confer specific resistance provide more
protection under these conditions.
Though women with more common alleles reported better
health, men did not rate them as appearing significantly
healthier or more attractive. It is unlikely that there are direct
allele-specific facial cues to health, and even more unlikely that
such cues can be reliably recognised. However, one might be
able to pick up a correlation between rated and reported health
in a larger study population due to the indirect effects of fitter
alleles. Individuals sporting fitter alleles could for instance have
increased symmetry or reduced scarring due to their superior
immune system. Men also did not rate HLA heterozygous
women significantly healthier or more attractive. Heterozygosity
may not be an important measure of fitness for the Tswana
population who are decidedly inbred because of a high incidence
of consanguineous (first cousin) marriages [32]. Regular in-
breeding leads to the purging of deleterious recessive alleles. This
may be an important difference between Roberts et al. [21] study
and ours. Furthermore, this study focused on female subjects,
whereas previous work has looked at males. Despite male
resource based contributions to offspring, selection on males may
not have been strong enough for them to detect more subtle
individual variations in attractiveness, as opposed to more
obvious features such as facial neoteny, averageness and
symmetry. In conclusion, we have found evidence for a relation-
s h i pb e t w e e nH L Aa n dh e a l t hi naS o u t hA f r i c a np o p u l a t i o n .
Allele frequency positively predicts health, presumably through
specific common alleles that confer resistance to infectious
pathogens. Future research will benefit from including pathogens
that impose a greater fitness cost than those pathogens tested
here. However, cues to health were not readily recognised in
facial features, and healthier individuals are therefore not rated
to be either healthier or more attractive.
MATERIALS AND METHODS
This project was cleared by the ethics committees of the University
of Pretoria (Text S1) and the University of the Witwatersrand
(Text S2).
(a) Sample group
Our sample group consisted of 59 female volunteers (age,
Mean=19.8, S.D.=1.56, Range=18–26). All participants iden-
tified themselves as Tswana, the most abundant Bantu-speaking
ethnic group at the University of Pretoria (V. Coetzee, un-
published data). Each volunteer signed a subject information and
consent form before taking part in the study (Text S3).
(b) Data collection
Participants completed a questionnaire, providing information
on their sex, age, hormonal contraceptive use, sexual prefer-
ence, self-rated health, number of illnesses in the previous year
and the number of cold and flu bouts per year (Text S4). Apart
from two participants, no one reported hormonal contraceptive
use in the previous year. Three participants reported being
homosexual.
Buccal cells were collected by scraping the inside of the mouth
for a minimum of ten strokes with a sterile nylon bristle cytology
brush. Brush tips were then stored in 300 ml cell lysis solution and
kept at room temperature for a maximum of 36 hours, well within
the recommended storage period.
All participants were photographed in full colour with a Sony
Cybershot DSC P72 (default settings with 3.1 Mega pixels fine,
Figure 6. The relationship between HLA-B allele frequency and the number of self reported cold and flu bouts per year. Outliers are indicated as
open circles.
doi:10.1371/journal.pone.0000640.g006
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PLoS ONE | www.plosone.org 6 July 2007 | Issue 7 | e640Soft light flash) under standard lighting conditions. Participants
were asked to maintain a neutral expression and were seated at
a fixed distance from the camera. Two photographs were taken of
each participant and the best one used for analyses. Slight lateral
tilting of individual faces was corrected by rotation around the
facial midline using vertical guidelines and cropped 5cm from each
side to standardize size in Coral Photo-Paint v. 10 (Coral
Corporation, Ontario, Canada). Next, faces were masked to
eliminate confounding factors (e.g., hairstyles) in Coral Knockout
v. 1.5 (Coral Corporation, Ontario, Canada). All images were
saved in 24-bit RGB colour at 72 dpi.
These masked photographs were used to compile 24 full colour
presentations consisting of 5 female photographs each. Presenta-
tions were rated by 59 Tswana male (age, Mean=21.1,
S.D.=2.11, Range=18–26) participants from the University of
the Witwatersrand, to minimise the probability of individuals
either recognising or being acquainted with the female partic-
ipants. Raters assessed opposite sex individuals for attractiveness,
perceived health and they also indicated whether or not they knew
the rated individual (Text S4). Raters indicated rated attractive-
ness and perceived health on a continuous line (142 mm), with
markings to indicate the ends, centre and quarter points. They
were instructed to place a clear mark across the line to indicate
their rating for each individual. Individuals that recognised any of
the rated individuals were given another presentation set to rate.
Rated attractiveness and health ratings were averaged for each
rated individual to yield an index of facial attractiveness and health
respectively. All volunteers were provided with lunch in return for
participation.
(c) HLA typing
We focused specifically on only two HLA loci, HLA-A and
HLA-B because these loci are important in all nucleated cells,
not just certain cells of the immune system. Genomic DNA was
extracted with the PuregeneH DNA Purification kit (Gentra
Systems, Inc., Minneapolis, USA), according to the manufac-
turers recommended protocol. After extraction, DNA was
resuspended in 20 mll o wT E( 1 0m MT r i s ,0 . 1m ME D T A ) .
Twenty eight samples with a total DNA content .480 ng were
typed for HLA-A and HLA-B using the Dynal RELI
TM SSO
typing kit (Invitrogen Corporation, California, USA) according
to manufacturers instructions. An additional 13 samples (total
DNA content .200 ng) were typed with the INNO-LiPA HLA-
A/B kits (Innogenetics group, Gent, Belgium), as this method
requires less total DNA. Collectively, these methods resolved
allele types on the two-digit allele group level for 41
participants. Three individuals showed ambiguous allele classi-
fications for HLA-B, such that one of the HLA-B alleles could
belong to one of two allele groups.
To test the first hypothesis that HLA heterozygosity positively
influences health and facial attractiveness, we calculated two
measures of heterozygosity. The first measure, as previously
defined by Roberts et al. [21], was the number of alleles shared at
both loci. Individuals that were heterozygous at both loci were
grouped as heterozygous, while individuals that were homozygous
at one or both loci were grouped as homozygous. The three
ambiguous allele classifications were all heterozygous for HLA-B
and were grouped accordingly.
For our second measure of heterozygosity, we calculated the
genetic distance between the two alleles of each locus and
averaged the value over both loci. Genetic distance should serve as
a more sensitive and continuous measure of heterozygosity than
the normal categorical heterozygosity and homozygosity. To
calculate genetic distance, we downloaded sequence data for all
alleles (4-digit) within a specific allele group (2-digit) from the
IMGT/HLA sequence database [33]. We did not download null
alleles, unconfirmed alleles and alleles that were shorter than the
bulk of the sequence data (HLA-A,1098 bp, HLA-B,1089 bp).
Homozygous individuals were assumed to have 4-digit alleles
identical by descent and therefore a distance of 0. Alleles were
aligned with Clustal W [34] available in BioEdit Sequence
Alignment editor v.7.0.5.2 [35] and the genetic distance calculated
using DNADist v.3.5c also available in BioEdit Sequence
Alignment Editor v.7.0.5.2 as the average distance between all
4-digit alleles within a 2-digit allele group. Separate general linear
models (GLM) were fitted for each dependent variable and both
measures of heterozygosity.
To test the second hypothesis that rare alleles are positively
correlated with health measures, we calculated the allele
frequency of HLA-A and HLA-B alleles in our sample group.
Each allele frequency was calculated as twice the number of
homozygous genotypes with that particular allele, plus the
number of heterozygous genotypes with that particular allele,
divided by two times the total number of individuals in the
sample population [36]. Allele frequencies were averaged across
both loci to produce a combined allele frequency. Separate
GLM analyses were fitted for each measure of health and facial
attractiveness.
All analyses were performed in SPSS version 13.0 (Chicago,
USA), alpha was set at 0.05 and all reported cases are two tailed.
In each analysis, we calculated Cook’s D [37] to identify influential
outliers with a critical value of Cook’s D.0.11, as determined by
Cook’s D=4/n, where n=the number of cases. Once identified,
influential outliers were removed from analyses. We report only
results obtained after the removal of influential outliers, unless
there was a difference in statistical significance, in which case we
report both results.
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